Elete Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.40 M
as on 17-11-2024
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.44 Cr
as on 17-11-2024
- Satisfied Charges ₹ 1.20 Cr
as on 17-11-2024
- Revenue 17.70%
(FY 2023)
- Profit 272.08%
(FY 2023)
- Ebitda 126.98%
(FY 2023)
- Net Worth 170.47%
(FY 2023)
- Total Assets -20.35%
(FY 2023)
About Elete Biotech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹2.44 Cr. The company has closed loans amounting to ₹1.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Prema Bedradi and Charavu Prasad serve as directors at the Company.
- CIN/LLPIN
U33100DL2017PTC321521
- Company No.
321521
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 2017
- Date of AGM
31 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Elete Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Charavu Prasad  | Director | 01-Aug-2017 | Current |
| Prema Bedradi | Director | 01-Aug-2017 | Current |
Financial Performance of Elete Biotech.
Elete Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.7% increase. The company also saw a substantial improvement in profitability, with a 272.08% increase in profit. The company's net worth Soared by an impressive increase of 170.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elete Biotech?
In 2023, Elete Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Accredited Consultants Private LimitedActive 17 years 20 daysPrema Bedradi and Charavu Prasad are mutual person
Accredited Logistics Private LimitedActive 2 years 3 monthsPrema Bedradi and Charavu Prasad are mutual person
- Prasadam Capital Private LimitedActive 3 years 5 months
Prema Bedradi and Charavu Prasad are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Feb 2023 | ₹2.24 Cr | Open |
Others Creation Date: 28 Feb 2023 | ₹1.95 M | Open |
Hdfc Bank Limited Creation Date: 29 Sep 2021 | ₹1.20 Cr | Satisfied |
How Many Employees Work at Elete Biotech?
Unlock and access historical data on people associated with Elete Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elete Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elete Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
